Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: ViiV Healthcare UK Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS
Retrovir 250 mg capsules, hard.
| Pharmaceutical Form |
|---|
|
Capsules, hard. Hard gelatin capsules with opaque blue cap and opaque white body coded GSJV2. |
Each capsule contains 250 mg zidovudine.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Zidovudine |
Zidovudine is an antiviral agent which is highly active in vitro against retroviruses including the Human Immunodeficiency Virus (HIV). |
| List of Excipients |
|---|
|
Capsule core: Maize starch Capsule coating: Titanium dioxide E171 Printing ink (black inks opacode 10A1 or 10A2): Shellac |
PVC/aluminium foil blister pack containing 40 capsules.
ViiV Healthcare UK Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS
PL 35728/0002
Date of first authorisation: 03 March 1987
Date of last renewal: 14 July 2011
| Drug | Countries | |
|---|---|---|
| RETROVIR | Austria, Australia, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
